SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000903423-18-000527
Filing Date
2018-10-02
Accepted
2018-10-02 16:46:58
Documents
1
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ettx.html 4  
1 OWNERSHIP DOCUMENT ettx.xml 4 15111
  Complete submission text file 0000903423-18-000527.txt   17465
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
BONDERMAN DAVID (Reporting) CIK: 0000860866 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181102003

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
COULTER JAMES G (Reporting) CIK: 0001099776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181102004

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Reporting) CIK: 0001495741 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181102002

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations